Viatris: Number of Employees 2010-2025 | VTRS

Interactive chart of Viatris (VTRS) annual worldwide employee count from 2010 to 2025.
  • Viatris total number of employees in 2024 was 32,000, a 15.79% decline from 2023.
  • Viatris total number of employees in 2023 was 38,000, a 2.7% increase from 2022.
  • Viatris total number of employees in 2022 was 37,000, a 0% decline from 2021.
  • Viatris total number of employees in 2021 was 37,000, a 17.78% decline from 2020.
Viatris Annual Employee Count
2024 32,000
2023 38,000
2022 37,000
2021 37,000
2020 45,000
2019 35,000
2018 35,000
2017 35,000
2016 35,000
2015 35,000
2014 30,000
2013 20,000
2012 20,000
2011 18,000
2010 13,000
2009 15,500
Sector Industry Market Cap Revenue
Medical Medical Services $10.833B $14.739B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $143.821B 26.97
CVS Health (CVS) United States $84.326B 10.48
Elevance Health (ELV) United States $78.255B 10.10
Cencora (COR) United States $58.178B 20.24
DiDi Global (DIDIY) China $23.485B 24.95
Natera (NTRA) United States $22.086B 0.00
Labcorp Holdings (LH) United States $21.684B 17.59
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.804B 0.00
Solventum (SOLV) United States $12.836B 13.59
CochLear (CHEOY) Australia $12.824B 0.00
ICON (ICLR) Ireland $12.156B 11.30
Revvity (RVTY) United States $11.802B 20.31
Avantor (AVTR) United States $9.247B 13.44
Medpace Holdings (MEDP) United States $9.225B 24.50
HealthEquity (HQY) United States $8.646B 37.87
Sonic Healthcare (SKHHY) Australia $8.518B 0.00
Charles River Laboratories (CRL) United States $7.808B 15.30
Caris Life Sciences,�Inc (CAI) United States $6.930B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.971B 29.27
BrightSpring Health Services (BTSG) United States $3.760B 34.50
Sotera Health (SHC) United States $3.296B 18.73
Surgery Partners (SGRY) United States $2.870B 37.32
Alignment Healthcare (ALHC) United States $2.750B 0.00
GeneDx Holdings (WGS) United States $2.622B 100.97
Concentras Parent (CON) United States $2.619B 15.13
Organon (OGN) United States $2.576B 2.74
Progyny (PGNY) United States $2.038B 44.87
Ardent Health (ARDT) United States $1.981B 8.45
PACS (PACS) United States $1.957B 0.00
Premier (PINC) United States $1.778B 13.49
GoodRx Holdings (GDRX) United States $1.739B 34.79
Teladoc Health (TDOC) United States $1.553B 0.00
Establishment Labs Holdings (ESTA) $1.303B 0.00
Pediatrix Medical (MD) United States $1.165B 8.86
CareDx (CDNA) United States $1.129B 17.64
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
Agilon Health (AGL) United States $0.948B 0.00
QDM (QDMI) Hong Kong, SAR China $0.846B 0.00
AMN Healthcare Services Inc (AMN) United States $0.833B 7.80
Nutex Health (NUTX) United States $0.643B 9.73
Embecta (EMBC) United States $0.619B 4.17
InnovAge Holding (INNV) United States $0.571B 0.00
SBC Medicals (SBC) United States $0.546B 0.00
LifeMD (LFMD) United States $0.535B 0.00
Sonida Senior Living (SNDA) United States $0.484B 0.00
Auna S.A (AUNA) Luxembourg $0.471B 10.62
So-Young (SY) China $0.440B 0.00
Omada Health (OMDA) $0.434B 0.00
Enhabit (EHAB) United States $0.368B 30.29
Performant Healthcare (PHLT) United States $0.335B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.330B 0.00
Beauty Health (SKIN) United States $0.263B 0.00
Oncology Institute (TOI) United States $0.216B 0.00
DocGo (DCGO) United States $0.159B 26.00
Pheton Holdings (PTHL) China $0.132B 0.00
Sera Prognostics (SERA) United States $0.100B 0.00
KindlyMD (NAKA) United States $0.074B 0.00
Basel Medical Group (BMGL) Singapore $0.067B 0.00
IceCure Medical (ICCM) Israel $0.062B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
ModivCare (MODV) United States $0.060B 0.00
Biodesix (BDSX) United States $0.046B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.037B 0.00
OSR Holdings (OSRH) United States $0.024B 0.00
Intelligent Bio Solutions (INBS) United States $0.013B 0.00
BioNexus Gene Lab (BGLC) $0.010B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
SeaStar Medical Holding (ICU) United States $0.008B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00